| Financial Year |
March 31 2023 |
| Monetary Funds |
93,022,500.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,755,742.32 |
| Accounts Receivable |
100,280,021.08 |
| Advances to Suppliers |
37,301.89 |
| Other Receivables |
48,774,571.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,882,732.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,273,643.20 |
| Total Current Assets |
645,940,562.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
93,789,881.84 |
| Investment Properties |
-- |
| Fixed Assetes |
37,858,778.92 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,588,093.54 |
| R&D expenses |
-- |
| Goodwill |
135,774,905.63 |
| Long-Term Deferred and Prepaid Expenses |
3,584,587.74 |
| Deferred Income Tax Assets |
59,234,681.45 |
| Other Non-Current Assets |
1,517,334.88 |
| Sub-Total of Non-Current Assets |
355,136,323.27 |
| Total Assets |
1,001,076,885.42 |
| Short-Term Loans |
208,128,358.59 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
-- |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
79,583,756.52 |
| Taxes Payable |
8,522,655.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
65,719,559.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,460,731.30 |
| Other Current Liabilities |
42,168,373.56 |
| Sub-Total of Current Liabilities |
455,237,963.90 |
| Long-term Loans |
7,130,027.61 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
375,687.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,824,962.30 |
| Total Liabilities |
480,062,926.20 |
| Paid-In Capital(Or Share Stock) |
136,322,000.00 |
| Capital Surplus |
134,065,794.95 |
| Surplus Reserve |
38,743,312.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
188,551,508.49 |
| Minority Stockholder's Interest |
23,331,343.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
497,682,616.21 |
| Owner's Equity（Stockholder's Equity） |
521,013,959.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,001,076,885.42 |
